Literature DB >> 16417872

Association of Duchenne muscular dystrophy with autism spectrum disorder.

Joyce Y Wu1, Karl C K Kuban, Elizabeth Allred, Frederic Shapiro, Basil T Darras.   

Abstract

We hypothesize that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur with a greater than random frequency. In this study, we set out to reject the hypothesis that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur no more often than expected by chance. Two index cases and six additional boys with concomitant Duchenne muscular dystrophy and autism spectrum disorder were identified in a muscular dystrophy clinic that approximates the total number of Duchenne muscular dystrophy boys (158) in the state of Massachusetts. The rate of prevalence (6 of 158) was compared with the prevalence rate of autism spectrum disorder in boys in the general population (1.6 in 1,000). We rejected the hypothesis that Duchenne muscular dystrophy and autism spectrum disorder co-occurrence was likely to be explained by chance (P = .006). We identify a previously unrecognized association of Duchenne muscular dystrophy with autism spectrum disorder. Further work might elucidate the level of association between these two conditions, either at the genetic or at the protein level, and might clarify, at least partially, the neurobiologic mechanisms associated with autism spectrum disorder.

Entities:  

Mesh:

Year:  2005        PMID: 16417872     DOI: 10.1177/08830738050200100201

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  39 in total

1.  Poor facial affect recognition among boys with duchenne muscular dystrophy.

Authors:  V J Hinton; R J Fee; D C De Vivo; E Goldstein
Journal:  J Autism Dev Disord       Date:  2006-12-20

2.  Increased density of dystrophin protein in the lateral versus the vermal mouse cerebellum.

Authors:  Wanda M Snow; Mark Fry; Judy E Anderson
Journal:  Cell Mol Neurobiol       Date:  2013-02-23       Impact factor: 5.046

3.  The dystrophin gene and cognitive function in the general population.

Authors:  Dina Vojinovic; Hieab H H Adams; Sven J van der Lee; Carla A Ibrahim-Verbaas; Rutger Brouwer; Mirjam C G N van den Hout; Edwin Oole; Jeroen van Rooij; Andre Uitterlinden; Albert Hofman; Wilfred F J van IJcken; Annemieke Aartsma-Rus; GertJan B van Ommen; M Arfan Ikram; Cornelia M van Duijn; Najaf Amin
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

4.  Conserved regions of the DMD 3' UTR regulate translation and mRNA abundance in cultured myotubes.

Authors:  C Aaron Larsen; Michael T Howard
Journal:  Neuromuscul Disord       Date:  2014-05-22       Impact factor: 4.296

Review 5.  Glycan susceptibility factors in autism spectrum disorders.

Authors:  Chrissa A Dwyer; Jeffrey D Esko
Journal:  Mol Aspects Med       Date:  2016-07-11

6.  Mutation screening of the ARX gene in patients with autism.

Authors:  Pauline Chaste; Gudrun Nygren; Henrik Anckarsäter; Maria Råstam; Mary Coleman; Marion Leboyer; Christopher Gillberg; Catalina Betancur
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-03-05       Impact factor: 3.568

7.  Autism spectrum disorders are prevalent among patients with dystrophinopathies.

Authors:  Haruo Fujino; Toshio Saito; Tsuyoshi Matsumura; Saki Shibata; Yuko Iwata; Harutoshi Fujimura; Osamu Imura
Journal:  Neurol Sci       Date:  2018-03-28       Impact factor: 3.307

8.  Neurobehavioral Concerns Among Males with Dystrophinopathy Using Population-Based Surveillance Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network.

Authors:  Kristin Caspers Conway; Katherine D Mathews; Pangaja Paramsothy; Joyce Oleszek; Christina Trout; Ying Zhang; Paul A Romitti
Journal:  J Dev Behav Pediatr       Date:  2015 Jul-Aug       Impact factor: 2.225

9.  Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis.

Authors:  Finale Doshi-Velez; Yaorong Ge; Isaac Kohane
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

10.  Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes.

Authors:  Darja Kanduc
Journal:  Biologics       Date:  2010-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.